ArticleBiotechnology letters2026
Mapping the membrane-enriched proteome of recombinant Chinese hamster ovary cells following induction of endoplasmic reticulum stress.
Article in Biotechnology letters, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
4 authors.
Funding
Abstract
objectiveChinese hamster ovary (CHO) cells are the dominant platform for monoclonal antibody (mAb) production. Despite their widespread use, an understanding of endoplasmic reticulum (ER) stress during recombinant protein production remains limited, often creating bottlenecks that hinder improvements in production titres and product quality. Because many critical regulators of protein folding, processing and quality control are membrane-embedded or membrane-associated, they are frequently underrepresented in whole-cell lysate proteomic analyses. In this study, we applied a membrane proteome enrichment strategy to selectively enhance detection of ER-resident and secretory pathway proteins and thereby improve the resolution of ER stress responses in recombinant CHO cell lines.
methodsSustained ER stress was induced using tunicamycin for 72 h in two IgG producing CHO cell lines, CHO DP-12 and NISTCHO. Membrane-enriched proteomes were analysed using label-free quantitative LC-MS/MS, followed by orthogonal validation using targeted LC-MS.
resultsMembrane enrichment expanded coverage of ER-resident and secretory pathway proteins, revealing minimal overlap with whole-cell lysate analyses. ER stress induced distinct, pathway-level changes in the two cell lines that were more clearly resolved in the membrane fraction. In CHO DP‑12 cells, ER stress resulted in decreased abundance of proteins involved in protein folding, oxidative folding, and glycosylation, together with altered abundance of proteins involved in ER-associated degradation (ERAD) suggesting remodelling of the ER quality-control network and a potential shift towards enhanced clearance of misfolded proteins. In contrast, NISTCHO cells showed more moderate changes, including increased abundance of several ER chaperones and oxidative folding proteins, alongside comparatively limited changes in degradation-related pathways. Targeted LC-MS using parallel reaction monitoring (PRM) confirmed the direction of regulation of a panel of these proteins, providing additional confidence in the observed trends.
conclusionsThis study highlights membrane proteomics as an important approach for studying ER-associated processes relevant to CHO cell function under ER stress conditions.
Indexed as
Identifiers
42762339What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.